Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-002451

Director bought 1,956 shares at an average $4.51 ($8,817)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2021-12-01 Purchase +75 $4.14 $311 181,260 D
Krogulski Kenneth Director 2021-12-02 Purchase +75 $3.84 $288 181,335 D
Krogulski Kenneth Director 2021-12-03 Purchase +75 $4.47 $335 181,410 D
Krogulski Kenneth Director 2021-12-06 Purchase +75 $4.46 $335 181,485 D
Krogulski Kenneth Director 2021-12-07 Purchase +75 $5.61 $421 181,560 D
Krogulski Kenneth Director 2021-12-08 Purchase +75 $6.15 $461 181,635 D
Krogulski Kenneth Director 2021-12-09 Purchase +75 $5.81 $436 181,710 D
Krogulski Kenneth Director 2021-12-10 Purchase +75 $4.82 $362 181,785 D
Krogulski Kenneth Director 2021-12-13 Purchase +200 $4.36 $872 181,985 D
Krogulski Kenneth Director 2021-12-14 Purchase +200 $4.28 $856 182,185 D
Krogulski Kenneth Director 2021-12-15 Purchase +200 $4.29 $858 182,385 D
Krogulski Kenneth Director 2021-12-16 Purchase +240 $4.53 $1,087 182,625 D
Krogulski Kenneth Director 2021-12-17 Purchase +240 $4.17 $1,001 182,865 D
Krogulski Kenneth Director 2021-12-20 Purchase +276 $4.33 $1,195 183,141 D
Open-market purchases · 1,956 sh · avg $4.51 · $8,817
Loading xslF345X03/doc4.xml…